Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

231 results about "Cell membrane permeability" patented technology

Membrane permeability is the quality of a cell's plasma membrane that allows substances to pass through it. Cells are like microscopic factories, and need a way to bring in raw materials for their processes - the cell membrane provides that route.

Pipeline deodorizing and cleaning effervescent tablet and preparation method thereof

The invention provides a pipeline deodorizing and cleaning effervescent tablet and a preparation method thereof. The raw materials for preparing the effervescent tablet include a deodorant, a foamingagent, a lubricant, a surfactant and a filler, wherein the deodorant is mainly used for eliminating odor-causing microorganisms and decomposing odorous substances and is mainly prepared from sodium dichloro isocyanurate, and the sodium dichloro isocyanurate has the advantages of having strong oxidization and chlorination properties, being safe, stable in chemical property, small in irritation, simple, small in dosage and long in lasting effect. Under the condition of the concentration of 20 ppm, a variety of bacteria, algae, fungi, germs and the like can be quickly killed. The deodorizing andcleaning mechanism is that sodium dichloro isocyanurate slowly releases hypochlorous acid when being in contact with water, changes the cell membrane permeability of odorous microorganisms and denatures proteins, enzymes and DNA cannot be synthetized properly, thus odor sources are rapidly eliminated, and its extremely strong oxidization property causes decomposition to produce sulfides and the like.
Owner:北京绿伞科技股份有限公司

Pig breed brucella bax inhibitor-1 (BI-1) gene deletion strain and construction method and application thereof

The invention discloses a pig breed brucella bax inhibitor-1 (BI-1) gene deletion strain and a construction method and application thereof. The strain is obtained by replacing a pig breed brucella BI-1 gene with a kanamycin resistance gene, and the method includes the main steps that a pig breed brucella S2 vaccine strain genome is taken as a template, PCR amplification is conducted to obtain an upstream homologous arm and a downstream homologous arm of the BI-1 gene, the upstream homologous arm and the downstream homologous arm of the BI-1 gene and a kanamycin resistance gene fragment also obtained through PCR amplification are together cloned into a pUC18 plasmid, and a homologous recombination deletion plasmid pUC18-BI1-KanR is obtained. The plasmid is used for electrotransformation ofa pig breed brucella competent cell, and through PCR identification, an obtained positive transformant is the pig breed brucella BI-1 gene deletion strain. Compared with a wild strain, the deletion strain shows the characteristics of decreasing the growth rate, reducing colonies, increasing cell membrane permeability, enhancing cell polymerization and the like, and it is indicated that the deletion strain has the potential of serving as a brucella attenuated live vaccine.
Owner:NORTHWEST A & F UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products